CD19 and acute lymphoblastic leukemia: Of the CD34−CD10+CD19+CD179a− population, the number of lymphoid cells in the common ALL BCR/ABL+ patients (mean: 3.7 subpopulations/patient) was reduced compared to the common ALL BCR/ABL− patients (mean: 8 subpopulations/patient).